FGFBP2 antibody (PE)

Catalog No. ABIN2663817

Product Details anti-FGFBP2 Antibody (PE)

Target: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This FGFBP2 antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Purification: The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.

Clone: TDA3

Isotype: IgG1 kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Protect from prolonged exposure to light. Do not freeze.

Storage: 4 °C

Storage Comment: The antibody solution should be stored undiluted between 2°C and 8°C.

Target Details for FGFBP2

Target: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Alternative Name: Ksp37 (FGFBP2 Products)

Synonyms: fb08g06 antibody, wu:fb08g06 antibody, HBP17RP antibody, KSP37 antibody, fibroblast growth factor binding protein 2 antibody, fibroblast growth factor binding protein 2a antibody, fibroblast growth factor binding protein 2 L homeolog antibody, FGFBP2 antibody, fgfbp2a antibody, fgfbp2.L antibody

Background: Ksp37 (killer-specific secretory protein of 37 kD), also known as FGFBP2 (FGF binding protein 2), is a 37 kD Th1-specific secretory protein. It is produced by NK cells, γ/δ T cells, a subset of effector CD8 T cells and Th1 cells, and secreted to serum. Most Ksp37 expressing cells coexpress perforin. It suggests that Ksp37 may be involved in an essential process of cytotoxic lymphocyte-mediated immunity. Elevated Ksp37 level in body fluids has been found in asthma and some infectious disease patients.